Targeted therapy for epithelial ovarian cancer: Current status and future prospects
- 1 November 2003
- journal article
- review article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 13 (6) , 701-734
- https://doi.org/10.1111/j.1525-1438.2003.13601.x
Abstract
No abstract availableKeywords
This publication has 164 references indexed in Scilit:
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomasGene Therapy, 2002
- Adenovirus-Mediated Thymidine Kinase Gene Therapy in Combination with Topotecan for Patients with Recurrent Ovarian Cancer: 2.5-Year Follow-UpGynecologic Oncology, 2001
- EGFR and cancer prognosisPublished by Elsevier ,2001
- Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian CancersThe American Journal of Pathology, 2000
- The Hallmarks of CancerCell, 2000
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomasEuropean Journal Of Cancer, 1994
- Advanced Ovarian Carcinoma: Molecular Evidence of Unifocal OriginGynecologic Oncology, 1993
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986